Literature DB >> 23869079

No familial aggregation in chronic myeloid leukemia.

Magnus Björkholm, Sigurdur Y Kristinsson, Ola Landgren, Lynn R Goldin.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23869079      PMCID： PMC3716206          DOI： 10.1182/blood-2013-05-501312

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Lynn R Goldin; Sigurdur Y Kristinsson; Xueying Sharon Liang; Asa R Derolf; Ola Landgren; Magnus Björkholm
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  Leukemia in Hiroshima atomic bomb survivors.

Authors:  R HEYSSEL; A B BRILL; L A WOODBURY; E T NISHIMURA; T GHOSE; T HOSHINO; M YAMASAKI
Journal:  Blood       Date:  1960-03       Impact factor: 22.113

Review 3.  Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industries. Part XXX: Causal relationship between chronic myelogenous leukemia and benzene-containing solvents.

Authors:  Myron A Mehlman
Journal:  Ann N Y Acad Sci       Date:  2006-09       Impact factor: 5.691

4.  Familial chronic myeloid leukaemia.

Authors:  D A Lillicrap; H Sterndale
Journal:  Lancet       Date:  1984-09-22       Impact factor: 79.321

5.  Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.

Authors:  Elisa Rumi; Francesco Passamonti; Matteo G Della Porta; Chiara Elena; Luca Arcaini; Laura Vanelli; Cecilia Del Curto; Daniela Pietra; Emanuela Boveri; Cristiana Pascutto; Mario Cazzola; Mario Lazzarino
Journal:  J Clin Oncol       Date:  2007-11-12       Impact factor: 44.544

6.  Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.

Authors:  Ola Landgren; Lynn R Goldin; Sigurdur Y Kristinsson; Elin A Helgadottir; Jan Samuelsson; Magnus Björkholm
Journal:  Blood       Date:  2008-05-01       Impact factor: 22.113

Review 7.  Chronic myelogenous leukemia and benzene exposure: a systematic review and meta-analysis of the case-control literature.

Authors:  Steven H Lamm; Arnold Engel; Kiran P Joshi; Daniel M Byrd; Rusan Chen
Journal:  Chem Biol Interact       Date:  2009-08-18       Impact factor: 5.192
  7 in total
  11 in total

1.  No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden.

Authors:  N Gunnarsson; M Höglund; L Stenke; F Sandin; M Björkholm; A Dreimane; M Lambe; B Markevärn; U Olsson-Strömberg; H Wadenvik; J Richter; A Själander
Journal:  Leukemia       Date:  2017-05-02       Impact factor: 11.528

2.  Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.

Authors:  N Gunnarsson; M Höglund; L Stenke; S Wållberg-Jonsson; F Sandin; M Björkholm; A Dreimane; M Lambe; B Markevärn; U Olsson-Strömberg; H Wadenvik; J Richter; A Själander
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

Review 3.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

4.  Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.

Authors:  Samer A Srour; Susan S Devesa; Lindsay M Morton; David P Check; Rochelle E Curtis; Martha S Linet; Graça M Dores
Journal:  Br J Haematol       Date:  2016-04-07       Impact factor: 6.998

5.  BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia.

Authors:  Aaron M Tsumura; Brian J Druker; Diana Brewer; Richard Press; Theodore P Braun
Journal:  JCO Precis Oncol       Date:  2021-02-19

6.  Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer.

Authors:  Marisa J L Aitken; Christopher B Benton; Ghayas C Issa; Koji Sasaki; Musa Yilmaz; Nicholas J Short
Journal:  Acta Haematol       Date:  2021-03-18       Impact factor: 2.195

7.  ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes.

Authors:  Xia Wu; Hao Cai; Yu Qiu; Jian Li; Dao-Bin Zhou; Xin-Xin Cao
Journal:  Orphanet J Rare Dis       Date:  2020-07-28       Impact factor: 4.123

8.  Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017.

Authors:  Qingqing Lin; Liping Mao; Li Shao; Li Zhu; Qingmei Han; Honghu Zhu; Jie Jin; Liangshun You
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

9.  B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib.

Authors:  Krzysztof Lewandowski; Michał Gniot; Maria Lewandowska; Anna Wache; Błażej Ratajczak; Anna Czyż; Małgorzata Jarmuż-Szymczak; Mieczysław Komarnicki
Journal:  Case Rep Med       Date:  2016-03-03

10.  Case of Patient with AML with Complex Karyotype including Ultra-Rare t(4;8)(q32;q13), t(4;11)(q21;p15) and Familial Aggregation of Myeloid Malignancies.

Authors:  Sławomir Milczarek; Ewa Studniak; Bartłomiej Baumert; Michał Janowski; Wioleta Bonda; Joanna Pietrzak; Aleksandra Łanocha; Edyta Paczkowska; Barbara Zdziarska; Bogusław Machaliński
Journal:  Medicina (Kaunas)       Date:  2022-01-10       Impact factor: 2.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.